MA
KITE

MUFG Americas’s Kite Pharma, Inc. KITE Stock Holding History

MUFG Americas’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-177
Closed -$18K – 1264
2017
Q2 		$18K Hold
177
– – ﹤0.01% 744
2017
Q1 		$14K Buy
177
+32
+22% +$1.98K ﹤0.01% 791
2016
Q4 		$7K Buy
145
+11
+8% +$540 ﹤0.01% 910
2016
Q3 		$7K Hold
134
– – ﹤0.01% 941
2016
Q2 		$7K Buy
134
+79
+144% +$3.88K ﹤0.01% 958
2016
Q1 		$3K Buy
+55
New +$2.66K ﹤0.01% 1095
2015
Q3 		– Sell
-120
Closed -$7K – 1279
2015
Q2 		$7K Buy
+120
New +$6.85K ﹤0.01% 937

Other funds holding KITE

CI
Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

MUFG Americas's KITE Position: Q3 2017 in Review

MUFG Americas sold out of Kite Pharma, Inc. (KITE) in Q3 2017, closing a stake of 177 shares — an estimated $18K sold.

MUFG Americas first reported a position in KITE in Q2 2015 and held it in 7 quarters. The position peaked at $18K in Q2 2017. 244 funds tracked by Wall St. Rank hold KITE as of Q3 2017.

  • MUFG Americas reported no remaining Kite Pharma, Inc. position as of Q3 2017 after selling out during the quarter.
  • MUFG Americas sold 177 Kite Pharma, Inc. shares in Q3 2017, an estimated $18K.
  • MUFG Americas first reported a position in Kite Pharma, Inc. in Q2 2015 and held it in 7 quarters.
  • MUFG Americas's Kite Pharma, Inc. position peaked at $18K in Q2 2017.
  • 244 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2017.

Based on MUFG Americas's 13F filing for Q3 2017, filed 13 Nov 2017.